The Immunogenicity Conference Stream brings together the FDA, industry leaders, and academic experts to explore key factors influencing immunogenicity and strategies for early prediction. Discussions will cover immunogenicity assay development, drug and target interference, pre-existing antibodies, and clinical relevance. With a focus on both traditional biologics and novel modalities—such as cell and gene therapies, RNA therapies, bispecifics, and ADCs—attendees will gain insights into immune response manipulation for therapeutic advantage while addressing safety concerns. Join us to stay at the forefront of immunogenicity research and innovation.

Conferences Include:

Keynote Presentations:

TBA